Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep >

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

   
Olena Yakobchuk/Shutterstock.comOlena Yakobchuk/Shutterstock.com

EASL 2021: Coronavirus

COVID-19 vaccine responses are weaker in liver transplant patients

News from EASL 2021

News from EASL 2021

Read our news stories from the International Liver Congress

Professor Rifaat Safadi of Hadassah University Hospital, Jerusalem, speaking at an International Liver Congress 2021 press briefingProfessor Rifaat Safadi of Hadassah University Hospital, Jerusalem, speaking at an International Liver Congress 2021 press briefing

EASL 2021: Coronavirus

Weaker COVID-19 vaccine responses seen in people with advanced liver fibrosis

Professor Li Xu of Sun Yat-sen University Cancer Centre, Guangzhou, China, speaking at the International Liver Congress 2021Professor Li Xu of Sun Yat-sen University Cancer Centre, Guangzhou, China, speaking at the International Liver Congress 2021

EASL 2021: Treatment for HCC

Immunotherapy plus arterial infusion chemotherapy shows promise for advanced liver cancer

Hepatitis bulletin

Hepatitis bulletin

Sign up for our monthly hepatitis bulletin.

infohep news

Latest library resources

Looking for country specific news, resources and services?

Looking for country specific news, resources and services?

Visit our country information pages >

Keep up to date with the latest hepatitis news

Keep up to date with the latest hepatitis news

Sign up for our free monthly email bulletin >